Cell migration is a highly controlled essential cellular process, often dysregulated in tumour cells, dynamically controlled by the architecture of the cell. Studies involving cellular fractionation and microarray profiling have previously identified functionally distinct mRNA populations specific to cellular organelles and architectural compartments. However, the interaction between the translational machinery itself and cellular structures is relatively unexplored. To help understand the role for the compartmentalization and localized protein synthesis in cell migration, we have used scanning confocal microscopy, immunofluorescence and a novel ribopuromycylation method to visualize translating ribosomes. In the present study we show that eIFs (eukaryotic initiation factors) localize to the leading edge of migrating MRC5 fibroblasts in a process dependent on TGN (trans-Golgi network) to plasma membrane vesicle transport. We show that eIF4E and eIF4GI are associated with the Golgi apparatus and membrane microdomains, and that a proportion of these proteins co-localize to sites of active translation at the leading edge of migrating cells.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
August 2011
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
July 27 2011
Translation initiation factors and active sites of protein synthesis co-localize at the leading edge of migrating fibroblasts Available to Purchase
Mark Willett;
Mark Willett
*Department of Biochemistry, School of Life Sciences, University of Sussex, Brighton BN1 9QG, U.K., and Laboratory of Viral Diseases, NIAID (National Institute of Allergy and Infectious Diseases), NIH (National Institutes of Health), Bethesda, MD 20892, U.S.A.
Search for other works by this author on:
Michele Brocard;
Michele Brocard
*Department of Biochemistry, School of Life Sciences, University of Sussex, Brighton BN1 9QG, U.K., and Laboratory of Viral Diseases, NIAID (National Institute of Allergy and Infectious Diseases), NIH (National Institutes of Health), Bethesda, MD 20892, U.S.A.
Search for other works by this author on:
Alexandre Davide;
Alexandre Davide
*Department of Biochemistry, School of Life Sciences, University of Sussex, Brighton BN1 9QG, U.K., and Laboratory of Viral Diseases, NIAID (National Institute of Allergy and Infectious Diseases), NIH (National Institutes of Health), Bethesda, MD 20892, U.S.A.
Search for other works by this author on:
Simon J. Morley
Simon J. Morley
1
*Department of Biochemistry, School of Life Sciences, University of Sussex, Brighton BN1 9QG, U.K., and Laboratory of Viral Diseases, NIAID (National Institute of Allergy and Infectious Diseases), NIH (National Institutes of Health), Bethesda, MD 20892, U.S.A.
1To whom correspondence should be addressed (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
March 09 2011
Revision Received:
April 14 2011
Accepted:
May 04 2011
Accepted Manuscript online:
May 04 2011
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2011 Biochemical Society
2011
Biochem J (2011) 438 (1): 217–227.
Article history
Received:
March 09 2011
Revision Received:
April 14 2011
Accepted:
May 04 2011
Accepted Manuscript online:
May 04 2011
Citation
Mark Willett, Michele Brocard, Alexandre Davide, Simon J. Morley; Translation initiation factors and active sites of protein synthesis co-localize at the leading edge of migrating fibroblasts. Biochem J 15 August 2011; 438 (1): 217–227. doi: https://doi.org/10.1042/BJ20110435
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |